---
audienceLevel: patient
cancerTypes:
- lung
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Tepotinib Hydrochloride - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/tepotinibhydrochloride
version: v1
---

# Tepotinib Hydrochloride - NCI

# Tepotinib Hydrochloride

Placeholder slot

(teh-POH-tih-nib HY-droh-KLOR-ide)

This page contains brief information about tepotinib hydrochloride
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Tepmetko

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80a0f1b9-071a-47f5-9e67-32d638a669dc&audience=consumer)

## Use in Cancer

Tepotinib hydrochloride
is approved to treat:

- **[Non-small cell lung cancer](/Common/PopUps/popDefinition.aspx?id=45323&version=Patient&language=English)** that has an abnormal *[MET](/Common/PopUps/popDefinition.aspx?id=794425&version=Patient&language=English)* gene. It is used in adults whose cancer has spread to other parts of the body.

Tepotinib hydrochloride
is also being studied in the treatment of other types of
cancer.

## More About Tepotinib Hydrochloride

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/660212) - Detailed scientific definition and other names for this drug.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Tepotinib Hydrochloride](https://www.cancer.gov/research/participate/clinical-trials/intervention/C171761) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
